Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Analysts hold a mixed view of Personalis: Ten firms collectively rate the stock “Hold,” with five hold, four buy and one sell rating. The average 12-month price target is $14.54, below the reported share price of $16.46.
• Personalis exceeded quarterly revenue expectations with $22.36 million, but its adjusted loss of $0.30 per share was wider than anticipated. The company remains unprofitable, with a negative net margin of 153.84%.
• Insiders sold shares recently, including transactions by the CFO and an SVP that were made to cover tax obligations from vested equity awards. Institutional investors own 61.91% of Personalis.

Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have earned a consensus rating of "Hold" from the ten ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $14.54.

Several equities analysts have recently weighed in on the company. Lake Street Capital cut Personalis from a "buy" rating to a "hold" rating and set a $16.25 price target for the company. in a research report on Monday, July 20th. Morgan Stanley increased their price objective on Personalis from $9.00 to $13.00 and gave the stock an "equal weight" rating in a report on Thursday, July 9th. TD Cowen reissued a "buy" rating on shares of Personalis in a report on Wednesday, July 15th. Weiss Ratings restated a "sell (d-)" rating on shares of Personalis in a research note on Friday, July 17th. Finally, Craig Hallum lowered Personalis from a "buy" rating to a "hold" rating and set a $16.25 target price for the company. in a report on Monday, August 24th.

Personalis Trading Down 0.7%

Shares of PSNL stock opened at $16.46 on Friday. The firm's 50 day moving average is $15.14 and its 200 day moving average is $11.10. The stock has a market capitalization of $1.72 billion, a P/E ratio of -15.10 and a beta of 2.31. Personalis has a 12 month low of $4.95 and a 12 month high of $18.89.

Personalis (NASDAQ:PSNL - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.04). Personalis had a negative net margin of 153.84% and a negative return on equity of 46.47%. The business had revenue of $22.36 million during the quarter, compared to analysts' expectations of $16.69 million. On average, equities analysts predict that Personalis will post -1.07 EPS for the current year.

Insider Activity

In other news, CFO Aaron Tachibana sold 2,931 shares of the firm's stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $16.22, for a total value of $47,540.82. Following the completion of the transaction, the chief financial officer directly owned 195,902 shares in the company, valued at approximately $3,177,530.44. This trade represents a 1.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Stephen Moore sold 2,068 shares of the business's stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $16.22, for a total transaction of $33,542.96. Following the transaction, the senior vice president directly owned 90,257 shares of the company's stock, valued at approximately $1,463,968.54. This represents a 2.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 121,438 shares of company stock valued at $1,844,664. Corporate insiders own 4.20% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in PSNL. Caitong International Asset Management Co. Ltd increased its holdings in shares of Personalis by 76.1% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,423 shares of the company's stock worth $27,000 after purchasing an additional 1,479 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Personalis in the second quarter worth $69,000. Jasper Ridge Partners L.P. bought a new stake in Personalis during the second quarter valued at $193,000. AXQ Capital LP bought a new stake in Personalis during the fourth quarter valued at $119,000. Finally, ADAR1 Capital Management LLC bought a new stake in Personalis during the second quarter valued at $201,000. 61.91% of the stock is currently owned by hedge funds and other institutional investors.

Personalis Company Profile

Personalis, Inc is a genomics company focused on precision oncology and advanced molecular testing. The company develops and commercializes genomic products designed to help identify, monitor and characterize cancer, supporting more informed treatment decisions and the development of targeted therapies.

Its offerings include tissue- and blood-based tumor profiling, liquid biopsy testing and immune profiling. Personalis' technologies are designed to detect and track tumor-derived signals, evaluate genomic alterations and provide insights into the interaction between cancer and the immune system.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.